This study was undertaken to examine the clinical utility of lactate clearance as an indicator of mortality in pediatric septic shock, and to compare the performance of lactate clearance at 6, 12, and 24 h for predicting in-hospital and 60-day mortality. Pediatric patients with septic shock were prospectively studied. Vital signs, laboratory values, Pediatric Risk of Mortality Score, and pediatric logistic organ dysfunction score were obtained at presentation (hour 0), hour 6, hour 24 and over the first 72 h of hospitalization. Lactate clearance was obtained at 6, 12, and 24 h of hospital admission. Therapy received, outcome parameters of mortality, and duration of hospitalization were recorded. The primary outcome variable of 60-day mortality rate was 31.25%. Only lactate clearance at 6 and 24 h was significantly associated with mortality, with odds of 0.97 (95% CI, 0.951-981; p < 0.001) and 0.975 (95% CI, 0.964-0.986; p < 0.001), respectively. Approximately there was a 24% decrease in likelihood of mortality for each 10% increase in lactate clearance at 24 h. At a threshold value of 10% 6-h lactate clearance had a sensitivity of 0.948 and specificity of 0.571, while at a threshold of 20% 24-h lactate clearance had a sensitivity of 0.922 and specificity of 0.629. The comparison of clearance at 6 and 24 h using receiver operating characteristic showed that former was ''fair'' (area under the curve ¼ 0.753) and later was ''good'' (area under the curve ¼ 0.81) in predicting mortality in pediatric septic shock. Conclusion: We concluded that optimal lactate clearance in pediatric septic shock both during the early presentation and after the initial ''golden hours'' is associated with lower in-hospital and 60-day mortality. Further, 24-h lactate clearance appears superior to 6 h lactate clearance in predicting mortality in such patients.
Introduction
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. 1 The third international consensus defined septic shock as a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with an increased risk of mortality than with sepsis alone. 1 Early recognition of patients at risk and aggressive treatment within the first few hours after presentation may prevent the invariable progression and poor outcome, manifested clinically by end-organ damage, failure of multiple organ systems, and death. 2, 3 Elevated serum lactate levels reflect the anaerobic metabolism related to cellular hypoxia and are thought to be an important marker of impaired tissue perfusion in patients with septic shock. 4 Small observational studies in adults and children have demonstrated that lactate can correlate with severity of shock and prognosis in sepsis. 5, 6 Whilst the sensitivity and specificity of single lactate concentrations as markers of tissue hypoperfusion have been debated 7, 8 studies have shown that serial measurements or lactate clearance (LC) over time may be better prognosticators of organ failure and mortality. [9] [10] [11] [12] [13] Further, studies in adults have established the use of lactate and LC as a diagnostic, prognostic, and therapeutic marker of global tissue hypoxia in sepsis and septic shock, however literature regarding its possible prognosticator role in pediatric septic shock is scanty. [14] [15] [16] Further, there is no data available regarding comparison of LC at different intervals during resuscitation of pediatric septic shock. This study was designed to examine the clinical utility of LC as an indicator of mortality in pediatric septic shock, and to compare the efficiency of LC at 6, 12, and 24 h for predicting in-hospital and 60-day mortality. We also defined a cutoff for LC that is associated with improved outcome after 6 and 24 h of intensive care intervention.
Materials and methods

Study design
This prospective observational study was performed in the pediatric intensive care unit (PICU) of Department of Pediatrics at SKIMS, which is an urban, academic medical center in Srinagar. The study was conducted over a period of two years from January 2015 to December 2016. The study was approved by hospital ethical committee. Informed consents were taken from the parents/ guardians of the study patients.
Participants
One hundred and twelve consecutive children in the age group of one month and 17 years, diagnosed with septic shock constituted the study group. Sepsis and septic shock were defined as per International pediatric sepsis consensus definitions. 17 Included patients were admitted through emergency department and immediately shifted to PICU, where they received central venous and arterial catheterization, and were managed as per the prescribed guidelines for goal directed and stepwise management of hemodynamic support in infants and children. 18 Patients were intubated and mechanically ventilated as required. We excluded neonates and patients above 17 years of age, children with diagnosed hepatic disease, diagnosed cases of inborn errors of metabolism, and patients who died within 24 h of hospitalization.
Data collection and data elements
The primary outcome variable was 60-day mortality. Demographic characteristics and admission diagnosis were collected at the baseline. Glasgow Coma Scale (GCS), baseline vital signs (temperature, heart rate, mean arterial pressure, central venous pressure), arterial lactate, laboratory values, and therapy received were recorded. Severity of critical illness was assessed using the Pediatric Risk of Mortality III (PRISM III) score within 24 h of hospital admission. Organ dysfunction was assessed and followed using pediatric logistic organ dysfunction (PELOD) score at 0 (at presentation), 6, 24, 48, and 72 h while in the hospital. Vasopressor use was assessed using vasoactive inotropic score (VIS). The VIS was calculated using the following formula: dopamine (mg/kg/min) Â 1 þ dobutamine (mg/kg/min) Â 1 þ epinephrine (mg/kg/min) Â 100 þ norepinephrine (mg/kg/ min) Â 100 þ phenylephrine (mg/kg/min) Â 100 þ vasopressin (U/kg/min) Â 10,000 þ milrinone (mg/kg/ min) Â 10. 19 Lactate levels were measured on admission to PICU along with other baseline investigations and septic work-up, and repeat lactate levels were taken at 6, 12, and 24 h post-admission. Lactate measurements were done using GEM Premier 3000 Bedford (USA).
LC definition
LC (%) was defined as: lactate at presentation minus lactate at follow-up, divided by lactate at presentation, then multiplied by 100. A positive value denotes a fall in serum lactate, whereas a negative value denotes a rise in lactate Lactate clearance ¼ (initial lactate À follow-up lactate) / initial lactate (1) We obtained LC at 6 h (LC 0-6 ), 12 h (LC 0-12 ), and at 24 h (LC 0-24 ) of hospital admission.
Statistical analysis
The statistical analysis was done using Statistical Package for Social Sciences (SPSS) version 20 and XLSTAT 2016. Univariate in-hospital mortality comparisons between survivors and non-survivors were done using either Student's t tests or Wilcoxon rank sum tests for the continuous variables and either chisquare tests or Fisher's exact tests for the categorical variables. The variables with significant univariate comparison (p < 0.05) were then included in a multivariate logistic regression model. Calibration of logistic model was done using the Hosmer-Lameshow goodness-of-fit test. 20 Results were presented as percent (%), median, interquartile range (IQR), and 95th percent confidence interval (95% CI). Optimal LC cutoffs were devised using receiver operating characteristic (ROC) curve. The ROC curves were compared by using Hanley's method. 21 Kaplan-Meier estimation was done to obtain 60-day survival curves for LC below and above the devised cutoff, which were then compared using the log-rank (Mantel-Cox) test for survival data. 
Results
Patient characteristics
During the two-year study period, 112 pediatric patients with septic shock met the eligibility criteria. 
Survivors versus non-survivors
Defining threshold and comparison of LC at different time intervals
Since there was no previous study in children defining LC after 6, 12, and 24 h, we devised optimal cutoffs (thresholds) using ROC curve. An optimal LC cutoff was defined as the LC with the maximum sum of sensitivity and specificity for predicting 60-day mortality (Figure 1 ). Based on LC cutoff we categorized the patients into two groups: low clearance group (<10% for 6 h and < 20 for 24 h) and high clearance group (>10% clearance and > 20 for 24 h). We did not categorize 12 h LC as it was not significant between survivors and non-survivors. Both the groups were comparable in terms of baseline characteristics like age, PRISM-III score, PELOD score, vital signs, serum lactate at presentation, laboratory values, and therapy given (Tables 2 and 3 ). However, the high clearance group had lower in-hospital and 60-day mortality, but a longer duration of hospital stay, compared with low clearance group (p < 0.05).
The comparison of LC 0-6 and LC 0-24 using ROC showed that former was fair (AUC ¼ 753) while as latter was good (AUC ¼ 0.81) in predicting 60-day mortality ( Table 4 ). 22 Kaplan-Meier estimation was used to obtain 60-day survival curves for LC below and above the threshold values ( Figure 2 ). The comparison of the survival curves using the log-rank test for survival data was significant for both 6 and 24 h LC (p < 0.05).
Discussion
Severity of critical illness and organ dysfunction assessed using the PRISM III and PELOD score, and lactate levels at presentation were similar in survivors and non-survivors. However, the LC 0-6 and LC 0-24 were higher in survivors compared to non-survivors. Our observations suggest that LC, as defined by the percentage of lactate cleared over a period of time after disease presentation, is an independent variable associated with decreased mortality rate. Assessment of the utility of serum lactate in critically ill patients has shown that both in the emergency department and in the intensive care setting, lactate levels have a role in risk-stratification. [23] [24] [25] Besides serial measurements, the duration and area under the curve of increased lactate levels are related to both morbidity and mortality in different patient groups. 26, 27 Studies have shown that during the most proximal stage of resuscitation, lactate levels seem to be more closely related to outcome than frequently used hemodynamic measurements, including oxygen delivery and oxygen consumption. 27 We observed that mortality was high in both sets of patients, those with LC 0-6 of <10% and the ones with LC 0-24 of <20%. However, LC 0-24 was a better predictor of mortality than LC 0-6 on comparison (AUC of 0.81 vs. AUC of 0.753 respectively). Several studies in adults, in severe sepsis, pointed out the value of blood LC in the first 6 h of resuscitation for the prediction of day-28 survival, 6, 28 but no data are available for longer duration. Few studies reported that septic patients with the lowest lactate value at 24 h, even with the same initial lactate concentration, had the highest survival rate. 2, 29 Some authors further observed that calculation and interpretation of LC appeared useful even after the initial ''golden hours'' and enabled detection of patients with a high risk of death. 30 To the best of our knowledge this is the first study in pediatric setting that compares LC at different intervals, and reports superiority of LC 0-24 over LC 0-6 during the management of pediatric septic shock. Comparing univariate variables in multivariate logistic regression model, we observed that there was an approximately 24% decrease in likelihood of mortality for each 10% increase in LC at 24 h. However, this observation was not consistent with LC 0-12 . In this study LC 0-12 besides being insignificant between survivors and non-survivors was poor (AUC ¼ 503) in predicting 60-day mortality. We attributed this observation to the fact that early goaldirected therapy targeted at improving hemodynamic parameters enhances LC 0-6 , but increase is consistent only in those patients who have sustained improvement in perfusion at 24 h. Further, studies have shown that sustained improvement in perfusion at 24 h independently predict survival in patient with septic shock. 31 Interpretation of the literature dealing with lactate in adults is complicated by variation in the choice of the ''optimal'' cutoff in clearance value with maximum efficiency for predicting in-hospital and 60-day mortality. 5, 6, 9, 10 In our study we defined a ''cutoff'' value of 10% for LC 0-6 and 20% for LC 0-24 using ROC curve. We observed that patients with higher LC (>10% at 6 h and >20% at 24 h) had decreased in-hospital and 60-day mortality rates. Munde et al. in their study in a pediatric setting observed that LC < 30% at 6 h predicted mortality with sensitivity of 75%, specificity of 97%, positive predictive value of 90%, and negative predictive value of 91.42%. 32 They concluded that LC in first 6 h of hospitalization was related to in-hospital mortality and PRISM score. 32 Choudhary et al. observed that a LC rate of <10% at 24 h had a sensitivity and specificity of 78.7% and 72.2%, respectively and a positive predictive value of 83.1% for death. 33 They concluded that failure to achieve a LC of more than 10% at 24 h was associated with greater risk of mortality (likelihood ratio þ 2.83; 95% CI ¼ 1.82-4.41). 33 In our study the longer duration of hospital stay in improved LC groups was attributed to the more number of survivors in these groups, and needed longer in-hospital care for complete recovery.
There are certain limitations to our study. First, it was an observational analysis whose results support an association and not necessarily causation, and does not necessarily mean that LC can be used as a therapeutic target at the studied intervals. Further the data were from a single medical center and the sample size was small, so the findings may not be generalized. Large, multicenter studies will be needed in order to confirm and generalize our results.
We concluded that optimal LC in pediatric septic shock both during the early presentation and after the initial ''golden hours'' is associated with lower inhospital and 60-day mortality. Further, 24 h LC appears superior to 6 h LC in predicting mortality in such patients. 
